3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Public Health -

Frozen blood a source of stem cells, study finds

Public HealthJul 02, 10

Frozen blood from stored samples can be used to make cells resembling stem cells, researchers said on Thursday - opening a potential new and easier source for the valued cells.

They used cells from blood to make induced pluripotent stem cells or iPS cells - lab-made cells that closely resemble human embryonic stem cells but are made from ordinary tissue.

These iPS cells have in the past been made from plugs of skin, but blood is much easier to take from people and to store, the researchers reported in the journal Cell Stem Cell.

“Blood is the easiest, most accessible source of cells, because you’d rather have 20 milliliters of blood drawn than have a punch biopsy taken to get skin cells,” Judith Staerk of the Whitehead Institute for Biomedical Research in Massachusetts, who worked on the study, said in a statement.

Stem cells are the body’s master cells, the source of renewed blood and tissue. So-called adult stem cells exist through life but they are partially developed.

Embryonic stem cells from days-old embryos have the ability to become all the cell types in the body and also can proliferate in the lab for years.

IPS cells are made by activating three or four genes that distinguish embryonic stem cells.

Whitehead’s Rudolf Jaenisch, who directed the work, said being able to use blood will open opportunities for researchers who want to use iPS cells to study how diseases develop.

“There are enormous resources - blood banks with samples from patients that may hold the only viable cells from patients who may not be alive any more, or from the early stage of their diseases,” Jaenisch said.

“Using this method, we can now resurrect those cells as induced pluripotent stem cells. If the patient had a neurodegenerative disease, you can use the iPS cells to study that disease.”

SOURCE:  Cell Stem Cell, July 2, 2010.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Sex and violence may not really sell products
  GPs and the Fit for Work scheme
  Study shows global warming is unlikely to reduce winter deaths
  Academies make recommendations for improving public health
  As death rates drop, nonfatal diseases and injuries take a bigger toll on health globally
  Designing better medical implants
  Single low-magnitude electric pulse successfully fights inflammation
  Total annual hospital costs could be reduced by rapid candidemia identification
  UTMB develops new online tool for nurses
  Online health information - keep it simple!
  Your privacy online: Health information at serious risk of abuse
  Physician guidelines for Googling patients need revisions

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site